Click below to learn more about Decipher.
Understand your risk. Personalize your treatment plan.
- Is active surveillance sufficient for me?
- Is localized treatment sufficient?
- Do I need more than one therapy [multi-modal therapy]?
The Decipher Biopsy test is the most accurate way to determine aggressiveness of your prostate cancer and assess your personal risk of metastasis. Using advanced whole genome technology, Decipher Biopsy provides valuable information to you and your doctor so that you can make more informed decisions about your next steps in managing your prostate cancer.
Decipher® Your Risk of Recurrence...
Decipher® is a transformative genomic test that informs decisions about the course of treatment for men after prostate surgery.
For patients, this means a personalized assessment of your risk of prostate cancer recurrence after prostatectomy.
Decipher measures the activity of certain genes in the tumor that are known to be involved in the development and progression of prostate cancer to tell you more about how your cancer may behave and develop.
The test analyzes a small tissue sample that was removed during surgery and is routinely archived or stored by the pathology laboratory. No additional procedures are required.